Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Monge

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Presse Medicale (Paris, France : 1983)|December 13, 2006
[Acquired idiopathic thrombotic thrombocytopenic purpura: arguments for an autoimmune disease]Paul Coppo, Agnès Veyradier, Matthieu Monge, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 27, 2005
Calcimimetics for predialysis patients?Albert Fournier, Irina Shahapuni, Laïd Harbouche, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 14, 2013
New drug therapies interfering with the renin-angiotensin-aldosterone system for resistant hypertensionMatthieu Monge, Aurélien Lorthioir, Guillaume Bobrie, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 20, 2010
Circulating cells and dialysis: improving cell number or increasing session number?Matthieu Monge, Anton Jan van Zonneveld, Ton J Rabelink
Journal of Hypertension|October 11, 2013
Can we use mineralocorticoid receptor blockade in diabetic patients with resistant hypertension? Yes we can! But it may be a double-edged swordMichel Azizi, Matthieu Monge, Aurélien Lorthioir, et al.
Biotechnology Progress|August 30, 2007
Development of a renal microchip for in vitro distal tubule modelsRégis Baudoin, Laurent Griscom, Matthieu Monge, et al.
International Journal of Cardiology|August 13, 2016
Dose-effect relationship of perindopril 10, 14 and 20mg assessed by urine and plasma AcSDKP levels in mildly sodium-depleted healthy volunteersMatthieu Monge, Valérie Paquet, Damien Bergerot, et al.
Genomics|May 15, 2012
Transcriptomic analysis of the effect of ifosfamide on MDCK cells cultivated in microfluidic biochipsLeila Choucha Snouber, Sébastien Jacques, Matthieu Monge, et al.
Nephrologie & Therapeutique|February 22, 2011
[Endothelial progenitor cells: what are we talking about?]Matthieu Monge, Ziad A Massy, Anton Jan van Zonneveld, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|April 5, 2011
Investigation into modification of mass transfer kinetics by acrolein in a renal biochipClelia Ramello, Patrick Paullier, Aissa Ould-Dris, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Presse Medicale (Paris, France : 1983)|December 13, 2006
[Acquired idiopathic thrombotic thrombocytopenic purpura: arguments for an autoimmune disease]Paul Coppo, Agnès Veyradier, Matthieu Monge, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 27, 2005
Calcimimetics for predialysis patients?Albert Fournier, Irina Shahapuni, Laïd Harbouche, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 14, 2013
New drug therapies interfering with the renin-angiotensin-aldosterone system for resistant hypertensionMatthieu Monge, Aurélien Lorthioir, Guillaume Bobrie, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 20, 2010
Circulating cells and dialysis: improving cell number or increasing session number?Matthieu Monge, Anton Jan van Zonneveld, Ton J Rabelink
Journal of Hypertension|October 11, 2013
Can we use mineralocorticoid receptor blockade in diabetic patients with resistant hypertension? Yes we can! But it may be a double-edged swordMichel Azizi, Matthieu Monge, Aurélien Lorthioir, et al.
Biotechnology Progress|August 30, 2007
Development of a renal microchip for in vitro distal tubule modelsRégis Baudoin, Laurent Griscom, Matthieu Monge, et al.
International Journal of Cardiology|August 13, 2016
Dose-effect relationship of perindopril 10, 14 and 20mg assessed by urine and plasma AcSDKP levels in mildly sodium-depleted healthy volunteersMatthieu Monge, Valérie Paquet, Damien Bergerot, et al.
Genomics|May 15, 2012
Transcriptomic analysis of the effect of ifosfamide on MDCK cells cultivated in microfluidic biochipsLeila Choucha Snouber, Sébastien Jacques, Matthieu Monge, et al.
Nephrologie & Therapeutique|February 22, 2011
[Endothelial progenitor cells: what are we talking about?]Matthieu Monge, Ziad A Massy, Anton Jan van Zonneveld, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|April 5, 2011
Investigation into modification of mass transfer kinetics by acrolein in a renal biochipClelia Ramello, Patrick Paullier, Aissa Ould-Dris, et al.
Pageof 4